The Missing Mushroom: Psychedelic Science and the Future of Psilocybin
Scientists know there’s more to magic mushrooms than just psilocybin. But as the psychedelic industry begins taking shape, could the mushroom itself be left behind?
Articles - Page 3
The Compounds in Psychedelic Cacti
Mescaline is the best-known phenethylamine in psychedelic cacti; but what about the other “minor” compounds in those cacti?
More Evidence of the Chemical Compound Variability in Magic Mushrooms
Data released by Filament Health shows why it’s important to understand the basic chemical makeup of magic mushrooms.
The Therapeutic Effects of Psychedelics: 2A or Not 2A?-Part 2
Some studies reveal that serotonin 2A receptor activation may not be necessary for the potential therapeutic effects of psychedelics.
Psychedelics and Perception Part 2: The First Era of Research
Reviewing early research (1895-1975) on changes in auditory perception.
MDMA: A Catalyst for ED-PTSD Treatment
MDMA supplements treatment of co-occurring trauma and eating disorders
Are Prodrugs the Next Wave of Psychedelic Drug Development?
The path toward therapeutic psychedelic-based drugs is becoming clearer as scientists understand more about how they are processed in the body.
Amanita muscaria – A Fresh Look at An Iconic Mushroom
People tread lightly with this psychoactive species because it contains toxic compounds. But what benefits may be hidden inside?
Fear of Death Impacts Quality of Life-How Psychedelics Can Help
Researchers suggest that the benefits of psychedelic treatment are mediated by a reduction in death anxiety and existential distress.
The Therapeutic Effects of Psychedelics: 2A or Not 2A? – Part 1
The serotonin 2A receptor is a major player in the psychedelic response, but it may not be the only one involved.